Skip to main content

Schmerztherapie bei Tumorpatienten

  • Chapter
  • First Online:
Schmerzbehandlung in der Palliativmedizin

Zusammenfassung

In etwa 60–90 % der Schmerzzustände bei Tumorpatienten sind durch Infiltration, Kompressionen mit konsekutiver Durchblutungsstörung, Ödem, Ulzeration oder Perforation direkt tumorbedingt. 10–25 % der Schmerzzustände sind therapiebedingt. Operation, Chemotherapie, Hormontherapie oder Radiatio können schmerzhafte Folgezustände wie z. B. Neuralgien, Phantomschmerz, Fibrose, Mukositis oder Ödem verursachen. Außerdem unterscheidet man zwischen tumorassoziierten Schmerzursachen wie z. B. Pneumonie, Pilzinfektion, Venenthrombose, Dekubitus (5–20 %) und tumorunabhängigen Schmerzursachen wie z. B. Migräne oder Arthrits (3–10 %). Neben somatischen Ursachen beeinflussen kulturelle, psychosoziale und spirituelle Faktoren das Schmerzerleben. Pathophysiologisch unterteilt man den Karzinomschmerz in den Nozizeptorschmerz und neuropathischen Schmerz bzw. gemischten Schmerz.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Cleary JF (2000) Cancer pain management. Cancer Control 7(2):120–131

    Article  CAS  PubMed  Google Scholar 

  • Eisenberg E, Carr DB, Chalmers TC (1995) Neurolytic celiac plexus block for treatment of cancer pain: a metaanalysis. Anesth Analg 80(2):290–295

    CAS  PubMed  Google Scholar 

  • Felleiter P, Gustorff B, Lierz P, Hornykewycz S, Kress HG (2005) Use of the World Health Organisation guidelines on cancer pain relief before referral to a specialized pain service. Schmerz 19(4):265–271

    Article  CAS  PubMed  Google Scholar 

  • Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH (2005) Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118(3):289–305

    Article  CAS  PubMed  Google Scholar 

  • Janig H, Pipam W, Lastin S, Sittl R, Bernatzky G, Likar R (2005) Pain experience and pain therapy of tumor patients in the view of general practitioners. Schmerz 19(2):97–108

    Article  CAS  PubMed  Google Scholar 

  • Lema MJ (2001) Invasive analgesia techniques for advanced cancer pain. Surg Oncol Clin N Am 10(1):127–136

    Article  CAS  PubMed  Google Scholar 

  • Maj S, Centkowski P (2004) A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland. Med Sci Monit 10(9):P193–P195

    Google Scholar 

  • Mercadante S, Fulfaro F, Casuccio A (2002a) A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis. Eur J Cancer 38(10):1358–1363

    Article  CAS  PubMed  Google Scholar 

  • Mercadante S, Radbruch L, Caraceni A, Cherny N, Kaasa S, Nauck F, Ripamonti C, De Conno F (2002b) Steering Committee of the European Association for Palliative Care (EAPC) Research Network. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer 94(3):832–839

    Article  PubMed  Google Scholar 

  • Munir MA, Enany N, Zhang JM (2007) Nonopioid analgesics. Med Clin North Am 91(1):97–111

    Article  CAS  PubMed  Google Scholar 

  • Platzer M, Likar R, Stein C, Beubler E, Sittl R (2005) Topical application of morphine gel in inflammatory mucosal and cutaneous lesions. Schmerz 19(4):296–301

    Article  CAS  PubMed  Google Scholar 

  • Sittl R, Nuijten M, Nautrup BP (2006) Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: a retrospective data analysis in Germany. Clin Ther 28(8):1144–1154

    Article  CAS  PubMed  Google Scholar 

  • Stute P, Soukup J, Menzel M, Sabatowski R, Grond S (2006) Analysis and treatment of different types of neuropathic cancer pain. J Pain Symtom Manage 26(6):1123–1131

    Article  Google Scholar 

  • Valeberg BT, Rustøen T, Bjordal K, Hanestad BR, Paul S, Miaskowski C (2008) Self-reported prevalence, etiology, and characteristics of pain in oncology outpatients. Eur J Pain 12(5):582–590

    Article  PubMed  Google Scholar 

  • Vissers KC, Besse K, Wagemans M, Zuurmond W, Giezeman MJ, Lataster A, Mekhail N, Burton AW, van Kleef M, Huygen F (2011) 23. Pain in patients with cancer. Pain Pract Sep–Oct 11(5):453–75. https://doi.org/10.1111/j.1533-2500.2011.00473.x. Epub 2011 Jun 17

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Likar, R., Köstenberger, M., Neuwersch-Sommeregger, S. (2023). Schmerztherapie bei Tumorpatienten. In: Bernatzky, G., Sittl, R., Likar, R. (eds) Schmerzbehandlung in der Palliativmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-64329-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-64329-7_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-64328-0

  • Online ISBN: 978-3-662-64329-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics